News

Tekmira’s SNALP technology encapsulates siRNAs in uniform lipid nanoparticles to deliver RNAi therapeutics to disease sites in numerous preclinical models. Tekmira carried out the studies in collaboration with

The agreement covers the distribution of medical infusions produced by Qatar Pharma in KSA in its first phase and dialysis solutions and medications in its second phase. Yousef

Reportedly, Global Health has the right at its discretion to sell shares of its common stock to LPC from time to time over a 30-month period in amounts

According to AstraZeneca, Cediranib met the co-primary endpoint of improving progression-free survival (PFS) but showed no improvement in overall survival (OS). AstraZeneca said that the adverse events associated

According to Applied BioCode, the CE Certification for the BioCode-1000 Analyzer proves that the anlyzer has met all relevant European Union consumer safety requirements. The CE Mark will

China Sky One Medical said that the new certificate will be valid until May 2015. Reportedly, SFDA’s examination committee had visited Tian Long in April to review its

The outcome of the trail has been notified to the investigators involved in the study and to the regulatory agencies. It has not noticed any new or unexpected

The new joint venture will be held at 51% by sanofi-aventis and at 49% by Nichi-Iko. In addition, sanofi-aventis is expected to acquire 1,524,500 shares of Nichi-Iko, to

The recalled products were manufactured for Blacksmith Brands by McNeil Consumer Healthcare, a Division of McNeil-PPC, (a Johnson & Johnson company) at McNeil’s Fort Washington, Pennsylvania plant. FDA